Return to Article Details
COST COMPARISON OF ORAL ANTIDIABETIC AGENTS AND INSULIN: EVALUATING AFFORDABILITY AND THE SHIFT TO INSULIN THERAPY IN RESOURCE-LIMITED SETTINGS
Download
Download PDF